Urinary tract infections (UTIs), which include any infection of the urethra, bladder or kidneys,
account for an estimated 400 million infections and billions of dollars in health-care …

The human urinary microbiome, also termed urobiome, has been overlooked due to the
clinical dogma of sterile urine, as reported by routine culture. However, evolving sensitive …

Traditional folk treatments for the prevention and management of urinary tract infections
(UTIs) and other infectious diseases often include plants and plant extracts that are rich in …

Background Urinary tract infections (UTI) are the most frequently diagnosed infection in
residents of long-term care and are a major risk factor for urosepsis, hospitalisation, and …

Staphylococcus saprophyticus is the leading Gram-positive cause of uncomplicated urinary
tract infections. Recent reports of increasing antimicrobial resistance (AMR) in S …

Enterococcus faecalis is the leading Gram-positive bacterial species implicated in urinary
tract infection (UTI). An opportunistic pathogen, E. faecalis is a commensal of the human …

This is a longitudinal study comprising 649 Escherichia coli isolates representing all 7,165
E. coli bloodstream infection (BSI) episodes recorded in a hospital (1996 to 2016). Strain …

Antibiotic therapy is the standard of care for urinary tract infections (UTIs) caused by
uropathogenic Escherichia coli (UPEC). However, previous antibiotic therapy may impart a …

Rising rates of antibiotic resistance in uropathogenic bacteria compromise patient outcomes
and prolong hospital stays. Consequently, new strategies are needed to prevent and control …

Allogeneic hematopoietic stem-cell transplant (allo-HSCT) is potentially curative for several
hematological disorders. Before stem-cell infusion, recipients undergo a conditioning …